Topic Paragraphs
FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Feb 27
El Abuelito Expands Recall to Include Queso Fresco, Quesillo, and Requeson Products Because of Possible Health Risk
Food & Beverages
Feb 26
The Quaker Oats Company Issues Voluntary Recall of Quaker Rice Crisps Sweet Barbecue Flavor Due to Undeclared Soy Issue
Food & Beverages
Feb 26
J&J Distributing (owned by New Harvest Foods) Recalls Multiple Products Because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
National Consumer Protection Week: FDA Is Vigilant in Protecting Consumers Against COVID-19 Vaccine Scams
The FDA is well-equipped to identify and thwart medical product scams while vaccine distribution is underway throughout the country.
Rare Disease Day 2021: FDA Shows Sustained Support of Rare Disease Product Development During the Public Health Emergency
As the FDA focuses on the COVID-19 pandemic, the agency also remains dedicated to its crucial role in development of treatments for rare diseases.
Reflections on a Record Year for Novel Device Innovation Despite COVID-19 Challenges
FDA achieved a record number of novel medical device authorizations in 2020.
Recently Published Guidances
Feb 22
Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID 19 Public Health Emergency
Drugs
Feb 22
Emergency Use Authorization for Vaccines to Prevent COVID-19
Biologics
Feb 22
Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests
Medical Devices